Table 5 Changes in AFP levels

From: Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields

Patient age and gender

AFP 6 months (ng ml−1)

Baseline AFP (ng ml−1)

8-week AFP (ng ml−1)

AFP variation (%)

Treatment duration (months)

End treatment status

Virus status

65 M

4.31

9.76

5.95

−39.0

3.0

Progression-death

HepC

67 F

888.3

9022.0

238.0

−97.3

11.7

GI bleed-death

HepC

64 M

4.7

4.5

2.6

−42.2

8.8

AMI-death

HepB

18 M

6.7

35.7

16.4

−55.7

7.8

Revoked consent-death

NOS

  1. Abbreviations: AFP=α-fetoprotein; AFP 6 months=AFP measured within 6 months before enrolment; AMI=acute myocardial infarction; baseline AFP=AFP at treatment initiation; GI=gastrointestinal; HepB=hepatitis B virus; HepC=hepatitis C virus; NOS=not otherwise specified; 8-week AFP=AFP at 8 weeks during treatment.
Back to article page